ESMO TAT 2023 | Highlights from ESMO TAT 2023 from Elena Garralda Cabanas

Elena Garralda Cabanas, MD, San Raffaele Scientific Institute, Milan, Italy, highlights the areas of interest to her at the ESMO TAT 2023 Congress. Identified by Dr Garralda Cabanas is the discussion of clinical trial methodology, including the introduction of new guidelines for Phase I trials. Also mentioned as a point of interest is the broad range of topics discussed at the congress, specifically the talk Dr Garralda Cabanas participated in on antibody drug conjugates (ADCs). This interview took place at the ESMO Targeted Anticancer Therapies (TAT) Congress in Paris, France.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.